Seeking Alpha

Transcept Pharmaceuticals (TSPT) receives a $10M milestone payment from Purdue Pharma following...

Transcept Pharmaceuticals (TSPT) receives a $10M milestone payment from Purdue Pharma following the FDA's inclusion of Intermezzo formulation patents in its Orange Book last week. The payment is part of an agreement between the two parties for the U.S. commercialization of the drug to be launched in Q2 of 2012. Shares +0.7% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)